FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Fresenius Medical Care AG & Co. KGaA Stock AnalysisComprehensive stock analysis for Fresenius Medical Care AG & Co. KGaA (FMS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisFMS
FMS
Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
FMS
Home🔹Stocks🔹Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA

🇺🇸FMS•NYSE

Fresenius Medical Care AG & Co. KGaA

🇺🇸FMS•NYSE
Market cap
$12.00B
Sentiment

Your view on FMS

Mkt Cap
$12.00B
Sentiment
Your view
FMS
Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
FMS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Fresenius Medical Care AG & Co. KGaA

Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Helen Giza
Headquarters
Else-KrOener Strasse 1, Bad Homburg, DE
Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Helen Giza
Headquarters
Else-KrOener Strasse 1, Bad Homburg, DE
Description

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally.

It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products.

In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services.

The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries.

Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Fresenius Medical Care AG & Co. KGaA, and the rating behind it. FMS last traded at $22.35, 11.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Fresenius Medical Care AG & Co. KGaA. Starting points for Fresenius Medical Care AG & Co. KGaA: P/E 11.6, EPS $1.75, beta 0.74 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA paid $0.86 per share over the last year — a 3.9% yield at the current $22.35 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Fresenius Medical Care AG & Co. KGaA. Trailing twelve-month EPS for Fresenius Medical Care AG & Co. KGaA stands at $1.75. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA has reported as a listed company since 1996. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Fresenius Medical Care AG & Co. KGaA valued side by side against its closest peers. Fresenius Medical Care AG & Co. KGaA is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Fresenius Medical Care AG & Co. KGaA, and how their positions are changing. At a $12.00B market value, institutional positions materially move Fresenius Medical Care AG & Co. KGaA's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Fresenius Medical Care AG & Co. KGaA executives and directors. Shares of Fresenius Medical Care AG & Co. KGaA have traded between $21.42 and $30.46 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA is a $12.00B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Fresenius Medical Care AG & Co. KGaA. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Fresenius Medical Care AG & Co. KGaA. Coverage tracks Fresenius Medical Care AG & Co. KGaA within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • DVA — DaVita Inc.
  • EHC — Encompass Health Corporation
  • ICLR — ICON Public Limited Company
  • RPRX — Royalty Pharma plc
  • SNN — Smith & Nephew plc
  • SOLV — Solventum Corporation
  • TEM — Tempus AI, Inc.

More Medical - Care Facilities companies

  • RHC.AX — Ramsay Health Care Limited
  • RHCGF — Ryman Healthcare Limited
  • RHEP — Regional Health Properties, Inc.
  • RHEPB — Regional Health Properties, Inc.
  • RHKJF — Rhoen-Klinikum AG
  • RKAGY — RHON-KLINIKUM AG Unsponsored ADR
  • RMSYF — Ramsay Health Care Limited
  • RMYHY — Ramsay Health Care Limited
  • RVLWF — Revitalist Lifestyle and Wellness Ltd.
  • RYHTY — Ryman Healthcare Limited
  • RYM.AX — Ryman Healthcare Ltd.
  • SCAL — Stem Cell Authority, Ltd.

ETFs holding Fresenius Medical Care AG & Co. KGaA

  • PZLV — Pzena U.S. Large Cap Value ETF (2.80%)
  • APIE — ActivePassive International Equity ETF (0.07%)
  • BFLX — iShares Flexible Equity Active ETF (0.03%)
  • DFAI — Dimensional - International Core Equity Market ETF (0.00%)
  • DFIV — Dimensional - International Value ETF (0.00%)
  • AVSD — Avantis Responsible International Equity ETF (0.00%)

News

Latest Market News